Participants 38 124 4
zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3
Participants 300 426 3
zidovudine (AZT)-treated asymptomatic human immunodeficiency virus (HIV)-infected subjects with 200-500 CD4 cells/mm3 at entry
Participants 432 444 5
352 subjects
